Please try another search
iBio, Inc., a biotechnology company, engages in the development of precision antibodies in the United States. It offers IBIO-100, a preclinical anti-fibrotic program for the treatment of systemic scleroderma and idiopathic pulmonary fibrosis; and EngageTx platform, which provides an optimized CD3 T-cell engager antibody panel. The company is also developing vaccine candidates, including IBIO-101, an antibody to reduce tumor growth; Endostatin E4 peptide for use in chemotherapy and immunotherapy; Trop-2 for the treatment Trop-2 positive cancers; MUC16, a tumor-associated epitope; anti-EGFRvIII antibody to treat glioblastoma and other cancers; CCR8 protein candidate for treatment of various cancers; PD-1 agonist for the treatment of rheumatoid arthritis and other inflammatory diseases; and IBIO-400 for the treatment of classical swine fever. iBio, Inc. has agreement with The Texas A&M University System for designing and manufacturing of plant-made biopharmaceuticals; and a research collaboration with the National Institute of Allergy and Infectious Diseases to investigate the potential of the company’s AI-driven epitope steering platform for the development of a vaccine for Lassa fever. The company was incorporated in 2008 and is headquartered in Bryan, Texas.
Name | Age | Since | Title |
---|---|---|---|
Vidadi M. Yusibov | 62 | 2004 | Member of Scientific Advisory Board |
Richard M. Silver | - | 2014 | Member of Clinical Advisory Board |
Evert B. Schimmelpennink | 51 | 2021 | Independent Director |
William D. Clark | 54 | 2021 | Independent Chairman |
Gary L. Sender | 61 | 2020 | Lead Independent Director |
Robert L. Erwin | 70 | 2008 | Member of Scientific Advisory Board |
Alexandra Kropotova | 50 | 2020 | Independent Director |
James Thomas Hill | 77 | 2008 | Independent Director |
Timothy Blackwell | - | 2014 | Member of Clinical Advisory Board |
Thomas A. Medsger | - | 2014 | Member of Clinical Advisory Board |
J. Terrill Huggins | - | 2014 | Member of Clinical Advisory Board |
Linda W. Armstrong | 60 | 2020 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review